TP53 and colonic neoplasm: Testing of this chain extended series on MDA-MB-231 cells, specifically endogenous mutant p53 knock down (R280K), and by reintroducing p53 R280K in cells lacking p53 expression, anti-proliferative activities against lung and colon cancer cell lines were demonstrated.